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Abdominal aortic aneurysm (AAA) rupture has
been historically associated with high operative mor-
tality rates, with numerous reports documenting
overall mortality rates of approximately 50%.1-5
Several factors have been found to influence mortali-
ty rate after the repair of a ruptured AAA (rAAA),
including clinical (patient age, platelet count, and
level of consciousness),2,6-9 aneurysm-specific
(suprarenal extension),2 and intraoperative (blood
loss) variables.6,10 Two potentially modifiable risk fac-
tors include the experience of the operating surgeon
and annual hospital volume of AAA operation.11-14
Although elective AAA repair has become progres-
sively safer in recent years, most studies have indicat-
ed that the mortality rate after rAAA repair has not
substantially diminished.13-15 Studies of outcome
after rAAA repair based on single-institution series can
reflect selection or referral bias, and there have been
few population-based cohort studies in which the
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outcome after rAAA repair was assessed.13-15 The cur-
rent study was undertaken to provide a contemporary
assessment of the outcome of rAAA surgery across a
broad spectrum of clinical practice and to identify fac-
tors influencing operative mortality and costs.
PATIENTS AND METHODS
We identified all patients undergoing operative
repair of an rAAA in all nonfederal acute care hospi-
tals in the state of Maryland between 1990 and 1995
by using the Maryland Health Services Cost Review
Commission (HSCRC) database. A combination of
search terms based on the International Classification
of Diseases, Ninth Revision, Clinical Modification
(ICD-9) codes was used to restrict the records to
patients with an rAAA who received an operative
repair of the aneurysm as the primary therapy: (1)
presence of a diagnostic code for rAAA (441.02 or
441.3) in the primary diagnostic code position, (2)
presence of a procedural code for AAA repair (38.34,
38.44, 38.64, 38.84, or 39.54) in the primary proce-
dural code position, and (3) presence of one of the 10
vascular diagnosis-related group (DRG) codes (5,
110-114, 119, 120, 478, or 479). Only records satis-
fying all three criteria were selected for examination.
This combination of search codes was used to elimi-
nate thoracoabdominal aortic aneurysms, nonrup-
tured AAA repairs, and aneurysm repair performed
secondary to another operation and to minimize cod-
ing errors. The algorithm was verified by examining
records at The Johns Hopkins Hospital and Sinai
Hospital of Baltimore; all records retrieved by the
algorithms were verified as appropriate, and no known
cases were excluded. Nonruptured AAA repairs were
identified by substituting the diagnostic code for non-
ruptured AAA (441.4) for the codes for rAAA in the
first portion of the search criteria listed above.
Patient variables that were analyzed included
race, gender, age, hypertension (diagnostic codes
401 to 405), smoking (diagnostic codes 305.1,
491.0, 472.1, or 528.6), diabetes (diagnostic code
250), heart disease (diagnostic codes 391, 394 to
398, 402, 404, 411 to 414, 416, or 425), chronic
obstructive pulmonary disease ([COPD] diagnostic
codes 415.0, 416.8 to 416.9, 491 to 494, or 496),
renal disease (diagnostic codes 585 to 586, V42.0,
V45.1, or V56),16,17 and medical complexity score.
The medical complexity score is determined with the
use of a proprietary software package at the HSCRC
that applies a stepwise quantitative and qualitative
algorithm that considers patient primary and sec-
ondary diagnoses to assess overall patient comorbid-
ity; it is graded in increasing severity from 1 through
4. However, because the algorithm is derived from
underlying risk factors otherwise included in the
logistic regression analysis (see below), the complex-
ity score was omitted from that analysis.
Outcomes that were studied included in-hospital
death, hospital length of stay (LOS), and total hos-
pital charges; in Maryland, hospital charges are
established by the HSCRC to reflect cost. Hospitals
were stratified as low- (n = 26), medium- (n = 13),
or high- (n = 6) volume institutions regarding rAAA
repair operations, defined as performing fewer than
10, 10 to 19, or 20 or more rAAA repairs through-
out the study period, respectively. Hospitals were
stratified as low- (n = 23), medium- (n = 12), or
high- (n = 12) volume institutions regarding AAA
operations, defined as performing fewer than 50, 50
to 99, or 100 or more nonruptured AAA repairs,
respectively. Surgeons were stratified as low- (n =
199), medium- (n = 20), or high- (n = 7) volume
surgeons if they performed 1 to 4, 5 to 9, or 10 or
more rAAA repairs, respectively. Maryland state
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Table I. Demographics and outcomes of 527 patients undergoing repair for rAAA
Factor Entire group Survivors Nonsurvivors
n 527 277 250
Age (yr, mean) 71.9 ± 8.5 69.7 ± 8.2 74.4 ± 8.2
Age (yr, range) 39 - 94 39 - 91 44 - 94
Medical complexity score 3.18 ± 0.04 3.10 ± 0.06 3.26 ± 0.06
Admitted from ED (%) 89.4 84.5 94.8
Mortality rate (%) 47.4 ± 2.2 0 100
LOS (days) 11.8 ±0.6 17.1 ± 0.9 6.0 ± 0.7
ICU LOS (days) 5.4 ± 0.3 6.5 ± 0.4 4.0 ± 0.5
Charge ($) 27,015 ± 957 30,640 ± 1378 22,999 ± 1273
Total charge ($ million) 14.2 8.49 5.75
ED, emergency department; ICU, intensive care unit.
All values are listed as mean ± SEM, except for age, where the mean ± SD is given. The difference in all variables between survivor and
nonsurvivor subgroups was statistically significant.
population data between 1990 and 1995 were pro-
vided by the Maryland Office on Aging. The inci-
dence of AAA and rAAA repair in the population
was calculated by comparing the number of AAA or
rAAA repairs throughout the state per year with the
state population in that year.
Categorical variables were analyzed by Pearson’s
c
2 test or Fisher’s Exact Test. Continuous variables
were analyzed by analysis of variance for parametric
variables and the Mann-Whitney U test or Kruskal-
Wallis test for nonparametric variables. Multiple
logistic regression was used for multivariate analysis.
RESULTS
Effects on rAAA mortality rate. Between 1990
and 1995, 3820 patients underwent AAA repair,
including 527 (13.8%) who presented with an rAAA.
The demographic characteristics of patients undergo-
ing rAAA repair are presented in Table I. The opera-
tive mortality rate increased significantly with advanc-
ing age (Table II). Although medical complexity
increased with advancing age, this trend was not sta-
tistically significant among the entire patient popula-
tion (Table II). There was, however, a significant cor-
relation between medical complexity score and age
among survivors of operative repair but not among
nonsurvivors, who had uniformly high complexity
scores (Table II).
Female patients were significantly older (75.0 ±
0.7 vs 71.2 ± 0.4 years; P < 0.0001, Mann-Whitney
U test) than male patients, but there was no differ-
ence in mean complexity score (3.2 ± 0.1 vs 3.2 ±
0.1 days, P = 0.87) between female and male
patients. Female patients experienced increased mor-
tality rates compared with male patients, although
this difference was not statistically significant (Table
III). Operative mortality rates also were higher in
white patients compared with black patients, but this
difference was not significant (Table III). The mean
age of white patients (72.0 ± 0.4 years) was not dif-
ferent from that of black patients (71.5 ± 2.0 years;
P = 0.946, Mann-Whitney U test), and there was no
difference in mean medical complexity score (3.2 ±
0.1 vs 3.2 ± 0.1, P = 0.54) between black and white
patients.
Operative mortality rate was unrelated to hospi-
tal rAAA and total AAA volume (Table IV). There
was no difference in mean patient age or medical
complexity scores among the low-, medium-, and
high-volume rAAA centers (Table IV). Although
there were no differences in mean age or medical
complexity scores among patients operated on by
high-, medium-, and low-volume rAAA surgeons,
patients undergoing operation by high-volume
rAAA surgeons had significantly lower postoperative
mortality rates (Table V).
By univariate analysis, the presence of hyperten-
sion, diabetes, and COPD was correlated with a sta-
tistically significant lower mortality rate, whereas the
presence of smoking, heart disease, and renal disease
was correlated with statistically insignificant decreases
(Table III). Multivariate analysis identified increased
mortality rate with increasing age and decreased mor-
tality rate with high surgeon volume, hypertension,
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Table II. Effect of age on rAAA outcome
Age group (yr) n Medical complexity score LOS (days) Charge ($) Mortality rate (%)
All patients
<65 99 3.02 ± 0.1 11.1 ± 1.9 25,066 ± 2017 28.3 ± 4.5
65 to 69 92 3.09 ± 0.1 12.6 ± 1.5 26,960 ± 2401 37.0 ± 5.1
70 to 79 240 3.23 ± 0.1 12.4 ± 1.0 28,248 ± 1498 51.7 ± 3.2
‡ 80 96 3.30 ± 0.1 10.4 ± 1.2 25,996 ± 1999 66.7 ± 4.8
P 0.163* 0.36* 0.51* <0.0001†
Survivors
<65 71 2.87 ± 0.1 14.4 ± 1.4 27,280 ± 2573
65 to 69 58 2.93 ± 0.1 16.4 ± 1.7 29,340 ± 2893
70 to 79 116 3.22 ± 0.1 19.0 ± 1.6 33,433 ± 2290
‡ 80 32 3.47 ± 0.1 17.6 ± 2.0 30,324 ± 3603
P 0.015* 0.007* 0.014*
Nonsurvivors
<65 28 3.39 ± 0.2 2.9 ± 1.0 19,454 ± 2655
65 to 69 34 3.35 ± 0.2 6.1 ± 2.3 22,899 ± 4192
70 to 79 124 3.23 ± 0.1 6.2 ± 1.0 23,397 ± 1861
‡ 80 64 3.27 ± 0.1 6.8 ± 1.3 23,831 ± 2371
P 0.74* 0.53* 0.95*
*Kruskal-Wallis test.
†c 2 test.
and pulmonary disease; there was no significant cor-
relation with gender, race, diabetes, smoking history,
cardiac disease, or renal disease (Table VI).
Effects on rAAA hospital LOS and charge.
Hospital LOS and mean charges were unrelated to
age among all patients but increased with age among
survivors of rAAA repair (Table II). There was no
difference in LOS (12.1 ± 1.7 vs 11.8 ± 0.6 days, P
= 0.65), intensive care unit (ICU) LOS (5.1 ± 0.8 vs
5.4 ± 0.4 days, P = 0.28), or hospital charge
($26,716 ± $2333 vs $27,092 ± $1044, P = 0.63)
between female and male patients. Similarly, there
was no difference in LOS (12.3 ± 2.1 vs 11.8 ± 0.6
days, P = 0.26), ICU LOS (4.4 ± 1.0 vs 5.4 ± 0.4
days, P = 0.70), or hospital charge ($29,485 ±
$3977 vs $26,866 ± $993, P = 0.21) between black
and white patients.
Although the mean LOS was longer and hospital
charges were higher at low-volume hospitals than at
medium- and high-volume hospitals, these differ-
ences were not significant (Table IV). However,
patients undergoing operation by high-volume
rAAA surgeons experienced a comparable LOS but
significantly lower hospital charges compared with
patients undergoing operation by low- and medium-
volume surgeons (Table V).
Trends over time. The incidence of AAA repair
varied insignificantly between 1.17 and 1.39 per
10,000 population during the course of the study,
and the incidence of rAAA repair remained stable
during the study interval, varying between 0.15 and
0.20 per 10,000 population, or 11% to 15% of all
AAA repairs (Table VII). However, despite a con-
stant number of rAAA repairs, operative mortality
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Table III. Effect of patient demographic and comorbid variables on rAAA mortality rate
Factor n Mortality rate (%) P*
Gender Female 108 51.9 ± 4.8 0.33
Male 419 46.3 ± 2.4
Race† White 494 48.2 ± 2.3 0.24
Black 28 35.7 ± 9.2
Hypertension Yes 135 33.3 ± 4.1 <0.0001
No 392 52.3 ± 2.5
Diabetes Yes 30 26.7 ± 8.2 0.023
No 497 48.7 ± 2.2
COPD Yes 115 36.5 ± 4.5 0.008
No 412 50.5 ± 2.5
Smoker Yes 10 30.0 ± 15.3 0.35
No 517 47.8 ± 2.2
Cardiac disease Yes 80 37.5 ± 5.4 0.07
No 447 49.2 ± 2.4
Renal disease Yes 9 44.4 ± 17.6 0.99
No 518 47.5 ± 2.2
*Fisher’s Exact Test.
†Five patients were listed as “other” and were omitted from the analysis.
Table IV. Effect of hospital volume on rAAA mortality rate
rAAA class AAA class
Age Medical complexity LOS Charge
Class n* Mortality (%) n† Mortality(%) (yr)‡ score‡ (days)‡ ($)‡
Low 147 45.6 ± 4.1 63 54.0 ± 6.3 71.4 ± 0.7 3.22 ± 0.08 14.0 ± 1.3 31,105 ± 2154
Medium 191 49.2 ± 3.6 189 46.0 ± 3.6 72.7 ± 0.6 3.24 ± 0.07 10.4 ± 1.0 25,243 ± 1471
High 189 47.1 ± 3.6 275 46.9 ± 3.0 71.6 ± 0.6 3.10 ± 0.07 11.6 ± 0.9 25,624 ± 1427
P 0.80§ 0.53§ 0.27|| 0.36|| 0.15|| 0.10||
*n is the total number of rAAA repairs per hospital rAAA class. rAAA class is based on fewer than 10 (n = 26 hospitals), 10 to 19 (n =
13), or 20 or more (n = 6) rAAA repairs per hospital.
†n is the number of rAAA repairs per hospital AAA class. AAA class is based on fewer than 50 (n = 23 hospitals), 50 to 99 (n = 12) or
100 or more (n = 12) total AAA operations.
‡Based on rAAA class.
§c 2 test.
||Kruskal-Wallis test.
declined from 59% to 43% during the study interval
(P = 0.039). This reduction in mortality rate over
the study period occurred although there was no
significant change in the mean age of patients under-
going rAAA repair or in the percentage of operations
performed by high-volume surgeons (Table VII).
DISCUSSION
This recent statewide experience, which docu-
mented an overall rAAA operative mortality rate of
47.4%, affirms the significantly lethal nature of this
condition and provides further insight into the fac-
tors influencing the outcome of operation. The cor-
relation between advanced age and increased opera-
tive mortality rate confirms previous work identifying
age as a significant predictor of mortality rate after
both elective6,18 and rAAA2,14,19 repair. Although it
is axiomatic that physiologic age is far more relevant
than chronologic age in influencing the outcome of
surgical interventions, the trend toward progressive-
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Table V. Effect of surgeon volume on rAAA mortality rate
Class n* Mortality rate (%) LOS (days) Charge ($) Age (yr) Medical complexity score
Low 315 50.8 ± 2.8 11.7 ± 0.8 27,362 ± 1283 72.1 ± 0.5 3.19 ± 0.06
Medium 121 47.1 ± 4.6 11.6 ± 1.0 28,575 ± 1748 72.1 ± 0.8 3.22 ± 0.09
High 91 36.3 ± 5.1 12.4 ± 1.8 23,740 ± 2356 71.3 ± 0.9 3.08 ± 0.10
P 0.05† 0.46‡ 0.018‡ 0.49‡ 0.39‡
*Surgeon class is based on 1 to 4 (n = 199 surgeons), 5 to 9 (n = 20), or 10 or more (n = 7) rAAA repairs per surgeon. n represents the
number of patients per surgeon class.
†c 2 test.
‡Kruskal-Wallis test.
Table VI. Multivariate analysis of factors affecting rAAA mortality rate
Variable* Regression coefficient Odds ratio 95% Confidence interval P†
Age 0.959 2.61 1.77 - 3.84 <0.0001
High-volume surgeon –0.616 0.54 0.33 - 0.88 0.014
Gender 0.167 1.18 0.75 - 1.87 0.474
Race –0.234 0.79 0.33 - 1.89 0.598
Hypertension –0.633 0.53 0.34 - 0.83 0.006
Diabetes –0.692 0.50 0.21 - 1.21 0.124
COPD –0.467 0.63 0.40 - 0.99 0.045
Smoking –0.449 0.64 0.15 - 2.68 0.540
Cardiac disease –0.248 0.78 0.45 - 1.34 0.369
Renal disease –0.198 0.82 0.20 - 3.39 0.785
*Age is ‡ 70 vs <70 years old; high-volume surgeons are compared with low- and medium-volume surgeons; race includes only white
and black patients.
†Forward and backward variable selection yielded identical significant variables.
Table VII. Incidence and mortality rates for AAA and rAAA by year
AAA rAAA
High-volume
Year incidence* n incidence* Mortality Age (yr) surgeons (%) LOS (days) Charge ($)
1990 1.39 91 0.19 59.3 ± 5.2 69.9 ± 0.9 19.8 13.2 ± 2.2 24,818 ± 2838
1991 1.34 82 0.17 53.7 ± 5.5 72.0 ± 0.9 13.4 12.6 ± 1.6 25,353 ± 2207
1992 1.31 75 0.15 49.3 ± 5.8 72.0 ± 1.0 20.0 10.8 ± 1.6 24,138 ± 2457
1993 1.36 100 0.20 43.0 ± 5.0 73.0 ± 0.8 18.0 12.1 ± 1.3 27,787 ± 2070
1994 1.17 91 0.18 37.4 ± 5.1 72.0 ± 0.7 15.4 10.4 ± 1.0 26,763 ± 1875
1995 1.22 88 0.17 43.2 ± 5.3 72.8 ± 1.1 17.0 11.8 ± 1.2 32,671 ± 2467
P 0.55† 0.039† 0.24‡ 0.57† 0.84‡ 0.003‡
*Number of AAAs or rAAAs per 10,000 population.
†c 2 test.
‡Kruskal-Wallis test.
ly higher medical complexity scores with advancing
age in the Maryland rAAA population is evidence of
more significant comorbidity among our older
patient cohorts (Table II). It is interesting that there
was no correlation between the medical complexity
score and age among the subgroup who did not sur-
vive operation. Although the nature of the HSCRC
database precluded documentation of the hemody-
namic status of the patient at presentation, it is likely
that the profound physiologic insult imposed by
aneurysm rupture overwhelmed any potential influ-
ence of associated comorbidity on outcome in many
of these cases.
In view of the rapid aging of the population and
the anticipated increase in the number of elderly
individuals who will present with aortic aneurysms
in the future, the operative mortality rate of 66.7%
among patients aged 80 and older is disconcerting.
Because the majority of patients presenting with an
rAAA are not aware of the presence of the lesion
before rupture20 and because AAA incidence
increases with advanced age,21 it is clear that the
greatest benefit of AAA screening programs and
referral for elective surgery should be realized
among the very elderly. This observation notwith-
standing, the current study supports an aggressive
surgical approach toward the elderly patient who
presents with an rAAA.22 Although the mortality
rate is higher than that in younger patients, survival
occurs frequently. Furthermore, recent studies have
demonstrated that elderly survivors of rAAA repair
are just as likely to resume their premorbid quality of
life as are younger rAAA survivors or elderly patients
who undergo elective aneurysm surgery.23 Although
the charges accrued by operative survivors increase
significantly with advancing age, those incurred by
nonsurvivors are not influenced by age (Table II).
A number of other demographic variables and
arteriosclerotic risk factors were examined in this
study for their possible influence on outcome. Only
21% of the patients presenting with rAAA were
women, which are consistent with previous studies.24
The proportion of women with aortic aneurysms
identified in autopsy and ultrasound studies has been
somewhat higher, suggesting a possible selection bias
in this and other surgical series.24 We observed a
somewhat higher mortality rate among female
patients, although the difference was not statistically
significant. This trend may reflect the significantly
older age of female patients undergoing operation or
other factors. A statewide analysis of intact AAA and
rAAA repair in Michigan also noted increased opera-
tive mortality rates among women,15 although the
results of other studies have not confirmed this influ-
ence of gender on the outcome of elective18,24 and
rAAA19,24 repair.
Although it was not surprising that multivariate
analysis demonstrated an association between age
and operative mortality rate, the observation that
hypertension and pulmonary disease were signifi-
cantly correlated with improved survival appears to
be contrary to conventional wisdom (Table VI). In
an analysis of 10,014 elective and rAAA repairs over
an 11-year period in Michigan, Katz et al.15 also
reported a significantly lower operative mortality
rate among patients with hypertension and no
increased mortality rate among patients with
COPD. There are a number of potential explana-
tions for these observations. Because the current
study and the report by Katz et al. retrospectively
reviewed insurance coding data, it may be argued
that patients identified as hypertensive or having
COPD were being actively treated for these condi-
tions, thus reducing their operative risk as opposed
to other patients in whom the conditions may have
existed but had not been identified and treated.
Second, it is possible that patients with relatively
mild manifestations of these conditions were being
captured by more aggressive coding strategies in
many hospitals, a phenomenon described as “DRG
creep” by others.15 Finally, one might also speculate
that many rAAA patients with the most severe
comorbidities died before reaching the hospital or
the operating room, thus introducing a selection or
underreporting bias into any assessment of the influ-
ence of those comorbid conditions on outcome.
Previous work has demonstrated an inverse rela-
tionship between rAAA operative volume and surgi-
cal outcome with respect to both operating sur-
geon13,14 and hospital caseload.14 The Maryland
experience demonstrated that our high-volume
rAAA surgeons are achieving optimal outcomes,
including reduced operative mortality rates and
lower hospital charges. This observation appears to
most likely reflect surgical expertise rather than
other confounding variables because the mean ages
and medical complexity scores were similar among
patients undergoing operation by the low-, medium,
and high-volume surgeons, respectively. On the
other hand, we could not relate surgical or financial
outcome to the hospital rAAA or unruptured AAA
operative volume (Table IV). Although high hospi-
tal volume often correlates with, and thus may be a
reasonable surrogate marker for, high individual
operative volume for a number of procedures, the
current observation implies that this assumption
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might not always be valid. It has previously been
suggested that optimal surgical outcome may be
achieved by concentrating complex cases in high-
volume institutions (i.e., by regionalizing care).11
Although in many cases the physiologic instability of
the patient with a presumed rAAA may preclude
this, our data offer compelling support for the goal
of directing patients to facilities with experienced
aneurysm surgeons, whenever possible.
Perhaps the most remarkable observation in the
current study was the significant reduction in the
statewide operative mortality rate over the past 6
years. We were not able to relate this improvement to
a decrease in the age of patients undergoing opera-
tion or the percentage of procedures performed by
our high-volume surgeons during this interval.
Several other community-based investigations have
failed to demonstrate a similar improvement in out-
come among patients undergoing rAAA repair,13-15
although the majority of these operations were per-
formed during the previous decade. It therefore is
not unreasonable to speculate that the reduced oper-
ative mortality rate among patients undergoing rAAA
repair most recently is a reflection of improvements
in intraoperative anesthetic management, postopera-
tive intensive care, and other factors that undoubted-
ly have contributed to the marked reduction in elec-
tive AAA operative mortality rate over the past two
decades, although confirmation of this cumulative
experience effect will require further study.
Finally, despite a greater awareness of aortic
aneurysms among the medical community and the
recognized mortality and morbidity rates associated
with rupture, we noted no change in the incidence
of rAAA during this interval in Maryland. In fact,
several other population-based studies have strongly
suggested an increase in the incidence of this condi-
tion in recent years.25-27 In addition to the substan-
tial mortality rate extracted by this condition, it rep-
resents an enormous financial burden on the health
care system. The mean hospital charge for all cases in
this analysis was $27,015 ± $957; it increased 33%
over the 6-year interval and exceeded $32,000 per
patient in 1995. Previous studies have indicated that
hospital charges associated with rAAA repair exceed
those of elective operation by 30% to 170%.20,23 It
was estimated that in 1979, approximately $50 mil-
lion would have been saved in the United States if all
rAAAs had undergone elective repair.20 It has been
understood for years that the key to reducing the
mortality rate and economic burden of aortic
aneurysm disease is early diagnosis and elective
repair. The Maryland experience suggests that refer-
ral of patients who require rAAA repair to experi-
enced aneurysm surgeons may improve outcome in
this patient cohort traditionally associated with high
operative mortality rates and cost.
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Dr Jay G. Robison (Mount Pleasant, SC). I appreciate
the opportunity to review this manuscript, and I congrat-
ulate the authors on their thought-provoking presenta-
tion. One of the strengths of this paper is the large num-
ber—527 ruptured aneurysms—reviewed over a recent 5-
year period. This gives a “snapshot” of contemporary
expectations for outcome after ruptured abdominal aortic
aneurysm, specifically the Maryland experience. The
authors attempt to tease out the factors influencing mor-
tality rates with a careful review of a statewide database for
demographic variables and for volume and experience
indicators. Not surprisingly, the authors found that overall
mortality rates remain high and that survivors cost more
to take care of than nonsurvivors, likely because the latter
have an early exit with a mean length of stay of about one
third that of survivors. What is interesting and somewhat
paradoxical is that lower mortality rates were seen with the
comorbitities of hypertension and chronic obstructive pul-
monary disease. Two thirds of patients over the age of 80
years died. Although surgeons with the greatest experi-
ence with ruptured abdominal aortic aneurysms had sig-
nificantly lower mortality rates, it is difficult to ascribe the
16% statewide decline in mortality rates over the study
interval to an increase in high-volume surgeon case load.
Here seems to be the crux of the issue. Because the
two potentially modifiable risk factors that the authors
examined (ie, operating surgeon and hospital wide experi-
ence) do not appear to account for the statewide decrease
in mortality rates, what does? The authors allude to possi-
ble explanations in their manuscript as varied as improve-
ments in anesthesia, postoperative intensive care, and
improved technical expertise. But because of the limita-
tions of the database available to them for analysis, the real
reasons remain elusive.
My first question regards other modifiable variables that
the authors must have considered that might not only have
had a profound influence on statewide outcomes, but could
conceivably skew apparent outcomes in favor of high-vol-
ume surgeons. How about stratifying outcome according to
delay in transport, delay in diagnosis, time to operation, and
degree of hemodynamic stability? Secondly, because only
patients who were operated were involved in this data analy-
sis, could this lead to a selection bias for patients who were
considered for surgery? After all, one of my mentors told me
that the key to successful vascular surgery is patient selec-
tion. Perhaps the high-volume surgeons have a sense of just
who not to operate on. Furthermore, we know that not all
ruptured aneurysms are the same. Is it important to distin-
guish a contained rupture from one with intraperitoneal
leak? Another observation has to do with the demographics
data. Of the 527 patients, only 10 had a smoking history
and only 16% had a history of cardiac disease. This is con-
trary to our own experience and to that of others. If correct,
these low risk factors may in part account for the decreasing
mortality rates in Maryland. If not accurate, it does raise
questions about the rest of the database. Lastly, I wonder if
the authors could correlate patient outcomes with the train-
ing of surgeons involved in regards to vascular fellowship
training. Were there more vascular surgeons in Maryland in
1995 than in 1990? There sure are in South Carolina. And
I wonder if the authors might speculate as to whether the
age of the surgeon might not be at least as important as the
age of the patient.
Dr Alan Dardik. Thank you very much for your
thoughtful discussion and comments. Regarding your first
and third questions, there are many variables of interest
that we cannot examine because they are not in the data-
base. For example, there may have been a delay in transport
or a delay in diagnosis in some of these patients.
Unfortunately, with the nature of the database, we cannot
determine that these are or are not present. Similarly, we
simply cannot determine contained versus free rupture
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because this is not coded in the database. There are codes
for elective versus urgent versus emergent repairs, but I do
not think that gets to your question.
The second question you had was whether there was a
selection bias by not operating. Again, with the nature of
the database, we cannot figure that out at all. The codes that
we used imply that we are looking at ruptured aneurysm
repairs and we are not looking at all presentations of rup-
tured aneurysms. We know that a large percentage of these
patients die before they reach the emergency room. In this
report, we just select out all repairs for ruptured aneurysms
because with this database we cannot examine patients who
did not come to the hospital and thus did not have a repair. 
The crux of this issue really is in your fourth question.
Why are there decreased numbers of smoking and cardiac
histories in these patients? The bottom line is that this is a
reimbursement-driven database. Is this data selected to
help us care for our patients? It is not. This is not an
aneurysm database where somebody carefully recorded all
the factors and tried to determine the true biologic
response after an event. What happens is these databases
are formed by coders at the hospitals and then the state
and the insurance companies use them to determine all
sorts of things, including capitation and payments. We
looked at this database to see the data that they are using.
In fact, we did determine that a lot of the risk factors, such
as smoking and cardiac disease, are significantly underrep-
resented in the data and that one cannot believe these
data. We believe that there is a tremendous statistical bias
in the data for factors like this that are not well coded. We
looked carefully among the literature to determine which
ICD9 codes could be used to determine preexisting dis-
ease as opposed to complications of disease in terms of
selecting patients and figuring out risk factors. And this is
really one of the more difficult aspects of the database. We
find it very interesting nonetheless that we actually can
learn things from the data (eg, high-volume surgeons have
better results).
And bringing us to your last question, can we deter-
mine the age or the training of the surgeon? The problem,
of course, is that it is an anonymous database. For exam-
ple, I know that surgeon number 304 had good data. On
the other hand, I do not know who he or she is or what
his or her age and training were.
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